Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study

被引:50
|
作者
Shoji, Fumihiro [1 ]
Miura, Naoko [2 ]
Matsubara, Taichi [1 ]
Akamine, Takaki [1 ]
Kozuma, Yuka [1 ]
Haratake, Naoki [1 ]
Takamori, Shinkichi [1 ]
Katsura, Masakazu [1 ]
Takada, Kazuki [1 ]
Toyokawa, Gouji [1 ]
Takenaka, Tomoyoshi [2 ]
Yamazaki, Koji [2 ]
Okamoto, Tatsuro [1 ]
Takeo, Sadanori [2 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[2] Natl Hosp Org, Dept Thorac Surg, Kyushu Med Ctr, Fukuoka, Japan
关键词
Elderly patients; Non-small-cell lung cancer; Immune-nutritional parameters; Postoperative comorbidities and outcome; ENHANCED RECOVERY; PERIOPERATIVE CARE; RISK INDEX; SURGERY; GUIDELINES; COMPLICATIONS; OUTCOMES;
D O I
10.1093/icvts/ivx337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: The world's population is rapidly ageing, and the age of patients with lung cancer will increase as well. The prognostic nutritional index, controlling nutritional status and the geriatric nutritional risk index (GNRI) are useful parameters for evaluating immune-nutritional status. We aimed to perform a multicentre retrospective study to investigate the correlations of these immune-nutritional parameters with postoperative comorbidities or surgical outcomes of elderly patients with non-small-cell lung cancer (NSCLC). METHODS: We selected 272 consecutive patients with NSCLC aged >75 years treated from January 2005 to December 2012 and evaluated 3 preoperative immune-nutritional parameters as potential predictive factors of postoperative comorbidities or as prognostic factors for surgically resected elderly patients with NSCLC. RESULTS: Prognostic nutritional index, GNRI, sex and preoperative respiratory comorbidities were significantly associated with postoperative comorbidities. Multivariate analyses revealed that preoperative GNRI, sex, preoperative serum carcinoembryonic antigen levels, preoperative serum cytokeratin 19 fragment levels, pathological N factor and pleural invasion were significantly associated with overall survival (OS). Abnormal GNRI was significantly associated with histology and outcomes. The Kaplan-Meier analysis of OS as a function of preoperative GNRI revealed that patients with an abnormal GNRI experienced significantly shorter OS compared with those with normal GNRI (5-year OS, 45.15% vs 64.10%, respectively; P = 0.0007, log-rank test). The controlling nutritional status score was not significantly associated with postoperative comorbidities or surgical outcomes. CONCLUSIONS: Preoperative GNRI is a novel preoperative predictor of postoperative comorbidities and a prognostic factor that may identify high-risk elderly patients with NSCLC.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 50 条
  • [41] PROGNOSTIC FACTORS OF DISEASE RECURRENCE AND OVERALL SURVIVAL IN ELDERLY VERSUS YOUNG PATIENTS IN SURGICALLY RESECTED NON SMALL CELL LUNG CANCER
    Al-Alao, B.
    Mc Govern, E. N.
    Young, V. N.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S48 - S48
  • [42] Prognostic significance of subclassification of stage IIB lung cancer: a retrospective study of 226 patients
    Yin, Nanchang
    Ha, Minwen
    Liu, Yu
    Gu, Huizi
    Zhang, Zetian
    Liu, Wei
    ONCOTARGET, 2017, 8 (28) : 45777 - 45783
  • [43] PREOPERATIVE NUTRITIONAL CONDITION AS A PROGNOSTIC FACTOR FOR LUNG CANCER IN ELDERLY PATIENTS
    Watanabe, I.
    Kanauchi, N.
    Watanabe, H.
    RESPIROLOGY, 2016, 21 : 78 - 78
  • [44] Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer
    Mazzaschi, Giulia
    Milanese, Gianluca
    Pagano, Paolo
    Madeddu, Denise
    Gnetti, Letizia
    Trentini, Francesca
    Falco, Angela
    Frati, Caterina
    Lorusso, Bruno
    Lagrasta, Costanza
    Minari, Roberta
    Ampollini, Luca
    Silva, Mario
    Sverzellati, Nicola
    Quaini, Federico
    Roti, Giovanni
    Tiseo, Marcello
    DATA IN BRIEF, 2020, 31
  • [45] Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
    Ohara, Shuta
    Suda, Kenichi
    Sakai, Kazuko
    Nishino, Masaya
    Chiba, Masato
    Shimoji, Masaki
    Takemoto, Toshiki
    Fujino, Toshio
    Koga, Takamasa
    Hamada, Akira
    Soh, Junichi
    Nishio, Kazuto
    Mitsudomi, Tetsuya
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 1915 - 1923
  • [46] Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study
    Xu, Tai
    Zhang, Si-Ming
    Wu, He-Ming
    Wen, Xiao-Min
    Qiu, Dong-Qin
    Yang, Yu-Yang
    Wang, Li-Zhen
    Zhu, Wen-Biao
    He, Li-Shan
    Li, Jian-Juan
    BMC CANCER, 2022, 22 (01)
  • [47] Prognostic significance of the Controlling Nutritional Status (CONUT) score in surgically treated breast cancer patients
    Huang, Zhang-Zan
    Song, Chen-Ge
    Huang, Jia-Jia
    Xia, Wen
    Bi, Xi-Wen
    Hua, Xin
    He, Zhen-Yu
    Yuan, Zhong-Yu
    GLAND SURGERY, 2020, 9 (05) : 1370 - 1379
  • [48] Clinicopathological and Prognostic Significance of EML4-ALK Rearrangement in Patients with Surgically Resected Lung Adenocarcinoma: A Propensity Score Matching Study
    Shi, Jinghan
    Gu, Weiqing
    Zhao, Yanfeng
    Zhu, Junjie
    Jiang, Gening
    Bao, Minwei
    Shi, Jingyun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 589 - 598
  • [49] Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer
    Seijiro Sato
    Mao Sato
    Hirohiko Shinohara
    General Thoracic and Cardiovascular Surgery, 2023, 71 : 354 - 362
  • [50] Retrospective study to examine prognostic value of c-reactive protein (CRP) in patients with surgically resected non-small-cell lung cancer (NSCLC).
    Azzoli, Christopher G.
    Huynh, Lynn
    Yi, Denise
    Cai, Beilei
    Duh, Mei Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)